BioCrude Technologies USA, Inc. financial data

Location
Montreal, Quebec, Canada
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 0.68% % -91%
Debt-to-equity -105% % 10%
Return On Equity 108% % -9.1%
Return On Assets -1414% % -104%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 50,854,726 shares 0.01%
Common Stock, Shares, Outstanding 50,854,726 shares 0.01%
Entity Public Float $0 USD
Common Stock, Value, Issued $50,855 USD 0.01%
Weighted Average Number of Shares Outstanding, Basic 50,798,915 shares 0%
Weighted Average Number of Shares Outstanding, Diluted 50,798,915 shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $0 USD
General and Administrative Expense $201,495 USD -19%
Operating Income (Loss) $201,495 USD 19%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $208,472 USD 18%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current $109 USD -100%
Property, Plant and Equipment, Net $10,250 USD -25%
Assets $10,359 USD -79%
Liabilities, Current $458,755 USD 51%
Liabilities $458,755 USD 51%
Accumulated Other Comprehensive Income (Loss), Net of Tax $27,460 USD -4.1%
Retained Earnings (Accumulated Deficit) $9,624,038 USD -2.2%
Stockholders' Equity Attributable to Parent $444,751 USD -77%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $303,035 USD -27%
Liabilities and Equity $10,359 USD -79%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $30,131 USD 62%
Net Cash Provided by (Used in) Financing Activities $30,131 USD -62%
Net Cash Provided by (Used in) Investing Activities $0 USD
Common Stock, Shares Authorized 75,000,000 shares 0%
Common Stock, Shares, Issued 50,854,726 shares 0.01%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $109 USD 43%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD
Deferred Tax Assets, Valuation Allowance $476,154 USD 14%
Depreciation $1,214 USD 12%
Payments to Acquire Property, Plant, and Equipment $0 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $38,557 USD -33%
Property, Plant and Equipment, Gross $37,374 USD 3.6%
Additional Paid in Capital $9,100,972 USD 0.18%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Interest Expense $6,977 USD 42%